Localized scleroderma secondary to mixed connective tissue disease during abatacept therapy
A 47‐year‐old woman with mixed connective tissue disease was treated with abatacept. After 2 months, a 3‐cm depression with atrophied surface was observed on her back, which had histopathological consistent with the symptoms of localized scleroderma. Although some cases of paradoxical reaction or cu...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-06-01
|
| Series: | Journal of Cutaneous Immunology and Allergy |
| Online Access: | https://doi.org/10.1002/cia2.12215 |